Tapan Sanghvi is a Scientific Fellow I of Formulation
Development at Vertex Pharmaceuticals Inc., Cambridge, MA. He leads
a team of dedicated scientists focused on preformulation
characterization, formulation design, process scale-up and
technology transfer for solid dosage forms.
Dr. Sanghvi is a leader in the development of drug delivery
technologies with a special focus on spray dry dispersions, making
significant advancements in this area as the pharmaceutical
development leader of telaprevir. He is a strong advocate for
Quality by Design and biopharmaceutical modeling. He has authored
many publications and made numerous presentations during his career
in the pharmaceutical industry.
He holds an M.B.A. in Marketing and Finance from the Institute
of Management Services in Indore (India) and a Ph.D. in
Pharmaceutical Sciences from the University of Arizona.